서브메뉴
검색
상세정보
Applications of Synthetic Biology for Emerging Biotechnology- [electronic resource]
Applications of Synthetic Biology for Emerging Biotechnology- [electronic resource]
상세정보
- 자료유형
- 학위논문(국외)
- 자관 청구기호
- 기본표목-개인명
- 표제와 책임표시사항
- Applications of Synthetic Biology for Emerging Biotechnology - [electronic resource] / Michael S. Belcher
- 발행, 배포, 간사 사항
- 발행, 배포, 간사 사항
- 형태사항
- 1 online resource(p.86 )
- 일반주기
- Source: Dissertations Abstracts International, Volume: 85-04, Section: B.
- 일반주기
- Advisor: Keasling, Jay;Scheller, Henrick.
- 학위논문주기
- Thesis (Ph.D.)--University of California, Berkeley, 2022.
- 이용제한주기
- This item must not be sold to any third party vendors.
- 요약 등 주기
- 요약As government and corporate policies transition to meet the UNs sustainable development goals as outlined in Agenda 2030, there will be a drastic need for the invention and refinement of "green technologies" applicable in a variety of economic sectors and disciplines. Biotechnology has become heavily influenced by the field of synthetic biology, which offers the capacity to deconstruct, shape, and rebuild natural systems from all domains of life. This is achieved via the development and integration of novel synthetic systems with natural biological processes. The potential of synthetic biology is now being realized as demonstrated by its application in numerous industries including (but not limited to): medicine, agriculture, food, energy (both bio and petroleum based), natural product discovery and production, pharmaceutical drug development, and materials science. Tools such as CRISPR-Cas9, along with the development of next generation DNA synthesis, assembly, and sequencing technologies, have unlocked the potential of synthetic biology. This has made the engineering and augmentation of most living systems possible, allowing for the development of complex and refined genetically modified organisms (GMOs) for deployment in numerous applications. The world is transitioning into the era of the Fourth Industrial Revolution, an era focused on the mitigation of climate change and the race to Net Zero. I envision that synthetic biology will play a crucial role in this transition, and while this space is much too vast for one person to explore in totality, scientists continue to work on independent components while exploring collaboration for the synergistic application of their discoveries. Eventually, the input from varying specialties form functional "high-level" systems developed with synthetic biology. In particular, the fields of synthetic plant biology and synthetic yeast biology have shown great promise for the development of breakthrough biotechnology platforms. The engineering of plants that serve as primary feedstocks for biofuel production (which generally has focused on maximizing the feedstock-to-fuel conversion efficiency through cell wall engineering) is now exploring the augmentation of current agricultural systems for the bioproduction of high-value biologics and therapeutics in planta. While still nascent in application, there is much promise for these technologies due to the scalability of in planta production, without the need for sterile conditions or complex manufacturing controls. The development of more efficient and versatile methods for the engineering of synthetic genetic circuits in plants is crucial for the deployment of the highly specialized plant chassis in biotechnological settings. Yeast, on the other hand, can serve as a counterpart to large-scale bioproduction in plants by providing a chassis for biochemical pathway discovery and complete biosynthesis of complex molecules from all domains of life. Yeast is a highly dynamic single-celled eukaryotic organism that has been highly characterized and is easily manipulated/engineered in the lab. In recent decades yeast has proven to be an effective platform for the bioproduction of various natural, specialty, and commodity chemicals whose manufacturing is not possible or cost effective with current methods. Additionally, yeast as a bioproduction platform offers the prospective of new-to-nature molecules through the coalescing of biosynthetic enzymes from disparate pathways. This is a truly exciting prospect for the future of drug discovery and development as we utilize the vast genetic diversity of the biological world for the construction of novel biosynthetic enzymes and pathways. The following sections aim to highlight my research focused on synthetic plant and yeast biology, with a focus on the development of technologies and strategies for application in the bioenergy and bioproduction sectors. While this alone will not answer all the existential problems of a transitioning world, it represents a small piece of a very large puzzle that we as a collective are working to solve.
- 주제명부출표목-일반주제명
- 주제명부출표목-일반주제명
- 주제명부출표목-일반주제명
- 비통제 색인어
- 비통제 색인어
- 비통제 색인어
- 비통제 색인어
- 비통제 색인어
- 부출표목-단체명
- 기본자료저록
- Dissertations Abstracts International. 85-04B.
- 기본자료저록
- Dissertation Abstract International
- 전자적 위치 및 접속
- 원문정보보기
- 소장사항
-
202402 2024
MARC
008240306s2022 s | s 0000c| eng d■001000016931880
■00520240214100321
■006m o d
■007cr
■020 ▼a9798380619622
■035 ▼a(MiAaPQ)AAI30246011
■040 ▼aMiAaPQ▼cMiAaPQ
■08204▼a610
■090 ▼a전자도서(박사논문)
■1001 ▼aBelcher, Michael S.
■24510▼aApplications of Synthetic Biology for Emerging Biotechnology▼h[electronic resource]▼cMichael S. Belcher
■260 ▼a[S.l.]▼bUniversity of California, Berkeley. ▼c2022
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2022
■300 ▼a1 online resource(p.86 )
■500 ▼aSource: Dissertations Abstracts International, Volume: 85-04, Section: B.
■500 ▼aAdvisor: Keasling, Jay;Scheller, Henrick.
■5021 ▼aThesis (Ph.D.)--University of California, Berkeley, 2022.
■506 ▼aThis item must not be sold to any third party vendors.
■520 ▼aAs government and corporate policies transition to meet the UNs sustainable development goals as outlined in Agenda 2030, there will be a drastic need for the invention and refinement of "green technologies" applicable in a variety of economic sectors and disciplines. Biotechnology has become heavily influenced by the field of synthetic biology, which offers the capacity to deconstruct, shape, and rebuild natural systems from all domains of life. This is achieved via the development and integration of novel synthetic systems with natural biological processes. The potential of synthetic biology is now being realized as demonstrated by its application in numerous industries including (but not limited to): medicine, agriculture, food, energy (both bio and petroleum based), natural product discovery and production, pharmaceutical drug development, and materials science. Tools such as CRISPR-Cas9, along with the development of next generation DNA synthesis, assembly, and sequencing technologies, have unlocked the potential of synthetic biology. This has made the engineering and augmentation of most living systems possible, allowing for the development of complex and refined genetically modified organisms (GMOs) for deployment in numerous applications. The world is transitioning into the era of the Fourth Industrial Revolution, an era focused on the mitigation of climate change and the race to Net Zero. I envision that synthetic biology will play a crucial role in this transition, and while this space is much too vast for one person to explore in totality, scientists continue to work on independent components while exploring collaboration for the synergistic application of their discoveries. Eventually, the input from varying specialties form functional "high-level" systems developed with synthetic biology. In particular, the fields of synthetic plant biology and synthetic yeast biology have shown great promise for the development of breakthrough biotechnology platforms. The engineering of plants that serve as primary feedstocks for biofuel production (which generally has focused on maximizing the feedstock-to-fuel conversion efficiency through cell wall engineering) is now exploring the augmentation of current agricultural systems for the bioproduction of high-value biologics and therapeutics in planta. While still nascent in application, there is much promise for these technologies due to the scalability of in planta production, without the need for sterile conditions or complex manufacturing controls. The development of more efficient and versatile methods for the engineering of synthetic genetic circuits in plants is crucial for the deployment of the highly specialized plant chassis in biotechnological settings. Yeast, on the other hand, can serve as a counterpart to large-scale bioproduction in plants by providing a chassis for biochemical pathway discovery and complete biosynthesis of complex molecules from all domains of life. Yeast is a highly dynamic single-celled eukaryotic organism that has been highly characterized and is easily manipulated/engineered in the lab. In recent decades yeast has proven to be an effective platform for the bioproduction of various natural, specialty, and commodity chemicals whose manufacturing is not possible or cost effective with current methods. Additionally, yeast as a bioproduction platform offers the prospective of new-to-nature molecules through the coalescing of biosynthetic enzymes from disparate pathways. This is a truly exciting prospect for the future of drug discovery and development as we utilize the vast genetic diversity of the biological world for the construction of novel biosynthetic enzymes and pathways. The following sections aim to highlight my research focused on synthetic plant and yeast biology, with a focus on the development of technologies and strategies for application in the bioenergy and bioproduction sectors. While this alone will not answer all the existential problems of a transitioning world, it represents a small piece of a very large puzzle that we as a collective are working to solve.
■590 ▼aSchool code: 0028.
■650 4▼aBioengineering.
■650 4▼aPlant sciences.
■650 4▼aBiochemistry.
■653 ▼aEmerging biotechnology
■653 ▼aSynthetic biology
■653 ▼aPlant biology
■653 ▼aBiofuel production
■653 ▼aGenetically modified organisms
■690 ▼a0202
■690 ▼a0479
■690 ▼a0487
■71020▼aUniversity of California, Berkeley▼bPlant Biology.
■7730 ▼tDissertations Abstracts International▼g85-04B.
■773 ▼tDissertation Abstract International
■790 ▼a0028
■791 ▼aPh.D.
■792 ▼a2022
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T16931880▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
■980 ▼a202402▼f2024
![Applications of Synthetic Biology for Emerging Biotechnology - [electronic resource] / Mic...](/Sponge/Images/bookDefaults/DDbookdefaultsmall.png)


한글
ENG
日本
中文
Việt Nam